These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20980803)

  • 21. NONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell lines.
    Tsofack SP; Garand C; Sereduk C; Chow D; Aziz M; Guay D; Yin HH; Lebel M
    Mol Cancer; 2011 Nov; 10():145. PubMed ID: 22118625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.
    El Fajoui Z; Toscano F; Jacquemin G; Abello J; Scoazec JY; Micheau O; Saurin JC
    Gastroenterology; 2011 Aug; 141(2):663-73. PubMed ID: 21683075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells.
    Xie G; Cheng K; Shant J; Raufman JP
    Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G755-63. PubMed ID: 19221016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells.
    Plasencia C; Martínez-Balibrea E; Martinez-Cardús A; Quinn DI; Abad A; Neamati N
    Int J Oncol; 2006 Jul; 29(1):225-35. PubMed ID: 16773204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. β-Cryptoxanthin Synergistically Enhances the Antitumoral Activity of Oxaliplatin through ΔNP73 Negative Regulation in Colon Cancer.
    San Millán C; Soldevilla B; Martín P; Gil-Calderón B; Compte M; Pérez-Sacristán B; Donoso E; Peña C; Romero J; Granado-Lorencio F; Bonilla F; Domínguez G
    Clin Cancer Res; 2015 Oct; 21(19):4398-409. PubMed ID: 26023082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Overexpression of Axin inhibits lymphoma cell invasion and metastasis in vitro by down-regulating β-catenin and MMP7/MMP9].
    Li ZJ; Ye JZ; Zhan LY; Zheng ML
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Mar; 36(3):423-8. PubMed ID: 27063176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
    Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
    Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LoVo colon cancer cells resistant to oxaliplatin overexpress c-MET and VEGFR-1 and respond to VEGF with dephosphorylation of c-MET.
    Mezquita B; Pineda E; Mezquita J; Mezquita P; Pau M; Codony-Servat J; Martínez-Balibrea E; Mora C; Maurel J; Mezquita C
    Mol Carcinog; 2016 May; 55(5):411-9. PubMed ID: 25647613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells.
    Pedraz-Cuesta E; Christensen S; Jensen AA; Jensen NF; Bunch L; Romer MU; Brünner N; Stenvang J; Pedersen SF
    BMC Cancer; 2015 May; 15():411. PubMed ID: 25981639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene and protein expression in the oxaliplatin-resistant HT29/L-OHP human colon cancer cell line.
    Xiang Z; Kang QJ; Xiang X
    Genet Mol Res; 2015 Sep; 14(3):11013-22. PubMed ID: 26400331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of Her2-Nrf2 axis in induction of oxaliplatin resistance in colon cancer cells.
    Pirpour Tazehkand A; Akbarzadeh M; Velaie K; Sadeghi MR; Samadi N
    Biomed Pharmacother; 2018 Jul; 103():755-766. PubMed ID: 29684854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways.
    Zhou ZP; Wang LP; Hong ZS; Qiu CZ; Wang MZ; Chen ZX; Tang LF; Yu WS; Wang CX
    Int J Oncol; 2018 Sep; 53(3):1183-1192. PubMed ID: 30015866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 dependent and independent sensitivity to oxaliplatin of colon cancer cells.
    Toscano F; Parmentier B; Fajoui ZE; Estornes Y; Chayvialle JA; Saurin JC; Abello J
    Biochem Pharmacol; 2007 Aug; 74(3):392-406. PubMed ID: 17559811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-Catenin-dependent lysosomal targeting of internalized tumor necrosis factor-α suppresses caspase-8 activation in apoptosis-resistant colon cancer cells.
    Han J; Sridevi P; Ramirez M; Ludwig KJ; Wang JY
    Mol Biol Cell; 2013 Feb; 24(4):465-73. PubMed ID: 23264463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gercumin synergizes the action of 5-fluorouracil and oxaliplatin against chemoresistant human cancer colon cells.
    Genovese S; Epifano F; Preziuso F; Slater J; Nangia-Makker P; Majumdar APN; Fiorito S
    Biochem Biophys Res Commun; 2020 Jan; 522(1):95-99. PubMed ID: 31740005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survivin promotes the invasion of human colon carcinoma cells by regulating the expression of MMP‑7.
    Gao F; Zhang Y; Yang F; Wang P; Wang W; Su Y; Luo W
    Mol Med Rep; 2014 Mar; 9(3):825-30. PubMed ID: 24425325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A silyl andrographolide analogue suppresses Wnt/β-catenin signaling pathway in colon cancer.
    Reabroi S; Chairoungdua A; Saeeng R; Kasemsuk T; Saengsawang W; Zhu W; Piyachaturawat P
    Biomed Pharmacother; 2018 May; 101():414-421. PubMed ID: 29501763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy.
    Tan S; Shi H; Ba M; Lin S; Tang H; Zeng X; Zhang X
    Int J Mol Med; 2016 Apr; 37(4):1030-8. PubMed ID: 26935807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of S100A4 in human cancer cell lines resistant to methotrexate.
    Mencía N; Selga E; Rico I; de Almagro MC; Villalobos X; Ramirez S; Adan J; Hernández JL; Noé V; Ciudad CJ
    BMC Cancer; 2010 Jun; 10():250. PubMed ID: 20515499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.